US Stem Cell Inc (USRM)

[andyshow]

“Fundamental shifts in venture capital investment strategies where financial sponsorship is now directed toward commercial or near commercial enterprises has required Bioheart to adapt its mission combining immediate revenue generating opportunities with longer-term development programs. Accordingly, Bioheart has developed a multifaceted portfolio of revenue generating products and services in its US Stem Cell Training, Vetbiologics and US Stem Cell Clinic subsidiaries that will, if successful, financially support its clinical development programs. Our goal is to maximize shareholder value through the generation of short-term profits that increase cash flows and decrease the need for dilutive equity financings – a modern biotechnology company development strategy.” - See more at: http://investorstemcell.com/investing/biohearts-steadfast-commitment/#sthash.YFYe1D6N.dpuf